These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12486962)

  • 1. [Granulocyte colony-stimulating factors as a support therapy in malignant diseases].
    Riikonen P; Elonen E; Teerenhovi L
    Duodecim; 2002; 118(21):2249-54. PubMed ID: 12486962
    [No Abstract]   [Full Text] [Related]  

  • 2. [Paradoxical myelosuppression with granulocyte-stimulating factor (G-CSF) and simultaneous administration chemotherapy].
    Sanz Ortiz J; Llamazares A; López-Vega JM
    Med Clin (Barc); 1993 Sep; 101(7):276. PubMed ID: 7538188
    [No Abstract]   [Full Text] [Related]  

  • 3. Clozapine and granulocyte colony-stimulating factor: potential for long-term combination treatment for clozapine-induced neutropenia.
    Mathewson KA; Lindenmayer JP
    J Clin Psychopharmacol; 2007 Dec; 27(6):714-5. PubMed ID: 18004146
    [No Abstract]   [Full Text] [Related]  

  • 4. Should the indications for the use of myeloid growth factors for the prevention of febrile neutropenia in cancer patients be extended?
    Klastersky J; Awada A; Aoun M; Paesmans M
    Curr Opin Oncol; 2009 Jul; 21(4):297-302. PubMed ID: 19509500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
    J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose and outcome: the hurdle of neutropenia (Review).
    Marangolo M; Bengala C; Conte PF; Danova M; Pronzato P; Rosti G; Sagrada P
    Oncol Rep; 2006 Aug; 16(2):233-48. PubMed ID: 16820898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prophylactic use of hematopoietic growth factors (G-CSF, GM-CSF) in prevention of chemotherapy-induced myelosuppression in children].
    Osińska-Królak M; Kurylak A; Wysocki M; Kurylak D; Kindracka A; Balcar-Boroń A
    Wiad Lek; 2003; 56(3-4):152-6. PubMed ID: 12923962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When the risk of febrile neutropenia is 20%, prophylactic colony-stimulating factor use is clinically effective, but is it cost-effective?
    Adams JR; Angelotta C; Bennett CL
    J Clin Oncol; 2006 Jul; 24(19):2975-7. PubMed ID: 16682722
    [No Abstract]   [Full Text] [Related]  

  • 10. [Indications for the use of granulocyte growth factors].
    Elonen E
    Duodecim; 1997; 113(22):2319-25. PubMed ID: 10892137
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
    Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
    J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of new European Organisation for Research and Treatment of Cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients.
    Zielinski CC; Awada A; Cameron DA; Cufer T; Martin M; Aapro M
    Eur J Cancer; 2008 Feb; 44(3):353-65. PubMed ID: 18191396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The American Society of Clinical Oncology guideline program.
    Winn RF; Smith TF
    Pharm Pract Manag Q; 1996 Apr; 16(1):31-8. PubMed ID: 10157738
    [No Abstract]   [Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
    Bhana N
    Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tale of two growth factors.
    Fruehauf JP; Kong KM; Wong SF; Chan HO
    Pharmacotherapy; 2006 Mar; 26(3):443-4; discussion 444. PubMed ID: 16503728
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization.
    Crea F; Giovannetti E; Zinzani PL; Danesi R
    Crit Rev Oncol Hematol; 2009 Oct; 72(1):21-44. PubMed ID: 19111474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of granulocyte colony-stimulating factor following hematopoietic cell transplantation: does haste make waste?
    Appelbaum FR
    J Clin Oncol; 2004 Feb; 22(3):390-1. PubMed ID: 14691127
    [No Abstract]   [Full Text] [Related]  

  • 18. Granulocyte colony-stimulating factor administration: adverse events.
    D'Souza A; Jaiyesimi I; Trainor L; Venuturumili P
    Transfus Med Rev; 2008 Oct; 22(4):280-90. PubMed ID: 18848155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte--colony-stimulating factor (Filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase myelogenous leukemia.
    Jørgensen HG; Copland M; Holyoake TL
    Cancer; 2005 Jan; 103(1):210-11. PubMed ID: 15540243
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
    Ozkaynak MF; Krailo M; Chen Z; Feusner J
    Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.